About the Authors

  • The Authors and Contributors of "Patent Docs" are patent attorneys and agents, many of whom hold doctorates in a diverse array of disciplines.
2018 Juristant Badge - MBHB_165
Juristat #4 Overall Rank

E-mail Newsletter

  • Enter your e-mail address below to receive the "Patent Docs" e-mail newsletter.

Enter your email address:

Delivered by FeedBurner

Contact the Docs

Docs on Twitter


Disclaimer

  • "Patent Docs" does not contain any legal advice whatsoever. This weblog is for informational purposes only, and its publication does not create an attorney-client relationship. In addition, nothing on "Patent Docs" constitutes a solicitation for business. This weblog is intended primarily for other attorneys. Moreover, "Patent Docs" is the personal weblog of the Authors; it is not edited by the Authors' employers or clients and, as such, no part of this weblog may be so attributed. All posts on "Patent Docs" should be double-checked for their accuracy and current applicability.
Juristat_165
Juristat #8 Overall Rank

Pharma-50-transparent_216px_red

« "Reform" at the U.S. Patent and Trademark Office | Main | Biotech/Pharma Docket »

March 23, 2011

Comments

Post after post, the more I see the less I like.

My Congressmen (and Senators) will hear from me AGAIN.

Good that you pointed this out Kev, I'll contact my rep in the house immediately, we'll get this bit of shinanigans taken care of quick as your uncle.

Counting on you, 6

Kevin -

Great catch. I am also troubled by the philosophical shift towards applicants and away from inventors. I shared my opinion on that previously, here:

http://gametimeip.com/2011/02/23/patent-reformers-favor-corporate-interests-over-inventors-rights/

and here:

http://gametimeip.com/2011/02/15/new-patent-reform-counterattack-dont-be-like-the-french/

The comments to this entry are closed.

November 2019

Sun Mon Tue Wed Thu Fri Sat
          1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30